SCHEMBL3479535

SCHEMBL3479535

CN1CCN(c2ccc(F)cc2F)c2ccc(Br)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTR6 P50406 4/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
SRD5A1 P18405 1/20 0.36
P2RX7 Q99572 4/20 0.35
HRH4 Q9H3N8 4/20 0.35
HTR3E A5X5Y0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3234227 0.90 ALDH1A1 (0.50) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL3236889 0.85 ALDH1A1 (0.42) ALDH1A1L3MBTL1HTR6CYP3A4CYP2D6
SCHEMBL3239742 0.83 ALDH1A1 (0.47) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL3479662 0.83 ALDH1A1 (0.50) ALDH1A1L3MBTL1HTR6CA12CA1
SCHEMBL3479627 0.82 ALDH1A1 (0.39) ALDH1A1L3MBTL1HTR6CYP3A4CYP2D6
SCHEMBL3480090 0.82 DRD1 (0.45) ALDH1A1L3MBTL1SRD5A1DRD2HTR2A
SCHEMBL3479780 0.82 SCN9A (0.43) ALDH1A1L3MBTL1HTR6CYP3A4CYP2D6
SCHEMBL3224500 0.81 SLC6A2 (0.48) ALDH1A1L3MBTL1P2RX7HRH4HTR3E
SCHEMBL3221318 0.81 ALDH1A1 (0.42) ALDH1A1L3MBTL1MC4RDRD2
SCHEMBL3479697 0.80 SCN9A (0.37) ALDH1A1L3MBTL1HTR6CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D ALDH1A1 372/4885L3MBTL1 2286/4885HTR6 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.